Cytomx Therapeutics Stock Forecast

Buy or Hold candidate since Jun 26, 2026 Gain 12.35%

The CytomX Therapeutics stock price gained 6.11% on the last trading day (Thursday, 2nd Jul 2026), rising from $3.60 to $3.82. During the last trading day the stock fluctuated 8.33% from a day low at $3.60 to a day high of $3.90. The price has risen in 7 of the last 10 days and is up by 29.05% over the past 2 weeks. Volume fell on the last day by -968 thousand shares and in total, 5 million shares were bought and sold for approximately $17.57 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

Given the current short-term trend, the stock is expected to fall -29.85% during the next 3 months and, with a 90% probability hold a price between $1.76 and $2.68 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

CTMX Signals & Forecast

Mostly positive signals in the chart today. The CytomX Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $3.56 and $3.38. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 31.27%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for CytomX Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $3.60 and $3.40. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, CytomX Therapeutics finds support just below today's level at $3.60. If this is broken, then the next support from accumulated volume will be at $3.40 and $2.93.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.300 between high and low, or 8.33%. For the last week, the stock has had daily average volatility of 8.61%.

The CytomX Therapeutics stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $3.71 (-2.94%) (This stock has high daily movements and this gives high risk. The RSI14 is 78 and this increases the risk substantially. There is a buy signal from a pivot bottom found 15 days ago.)

Trading Expectations (CTMX) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect CytomX Therapeutics to open at $3.77, and during the day (based on 14 day Average True Range), to move between $3.71 and $3.93, which gives a possible trading interval of +/-$0.220 (+/-5.93%) up or down from last closing price. If CytomX Therapeutics takes out the full calculated possible swing range there will be an estimated 5.93% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.60 (5.76%) than the resistance at $4.25 (11.26%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is CytomX Therapeutics stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 2.393 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 6, 2026 - $3.77 ( 1.22%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk